Good afternoon :)
Place Order
Add to Watchlist

Mercury Laboratories Ltd

MERCURYLAB Share Price

829.100.50% (+4.10)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹102 cr, stock is ranked 3,012

Stock is 3.49x as volatile as Nifty

MERCURYLAB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹102 cr, stock is ranked 3,012

Stock is 3.49x as volatile as Nifty

MERCURYLAB Performance & Key Metrics

MERCURYLAB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
32.592.010.41%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.656.550.83%

MERCURYLAB Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

MERCURYLAB Company Profile

Mercury Laboratories Limited is a pharmaceutical company engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations.

MERCURYLAB Similar Stocks (Peers)

Compare with peers Compare with peers 

MERCURYLAB Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.18
36.18
1Y Return
13.20%
13.20%
Buy Reco %
87.88
87.88
PE Ratio
22.95
22.95
1Y Return
2.92%
2.92%
Buy Reco %
74.19
74.19
PE Ratio
19.32
19.32
1Y Return
10.98%
10.98%
Buy Reco %
56.67
56.67
PE Ratio
57.15
57.15
1Y Return
10.81%
10.81%
Buy Reco %
72.00
72.00
PE Ratio
48.88
48.88
1Y Return
4.22%
4.22%
Buy Reco %
81.25
81.25
Compare with Peers

MERCURYLAB Forecast

MERCURYLAB Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

MERCURYLAB

MERCURYLAB

Income

Balance Sheet

Cash Flow

MERCURYLAB Income Statement

MERCURYLAB Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 6.27%, vs industry avg of 9.03%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.03% to 0.02%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 14.83%, vs industry avg of 15.28%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue48.3752.2856.5658.1269.4858.8677.0576.6576.1776.17
Raw Materialssubtract19.8024.5524.5924.8031.0123.8830.9630.4568.0868.09
Power & Fuel Costsubtract1.181.241.311.621.591.151.621.87
Employee Costsubtract6.907.347.839.309.8012.5014.2414.50
Selling & Administrative Expensessubtract11.2513.3812.0212.1212.4011.7515.5314.56
Operating & Other expensessubtract2.180.944.053.264.211.654.415.15
Depreciation/Amortizationsubtract1.291.471.631.871.922.452.482.822.882.88
Interest & Other Itemssubtract0.890.911.090.820.640.450.360.380.550.55
Taxes & Other Itemssubtract2.190.441.211.102.571.471.861.271.521.52
EPS22.4216.7523.5826.9244.5029.6746.5847.0826.2126.08
DPS1.501.501.502.003.503.503.503.503.503.50
Payout ratio0.070.090.060.070.080.120.080.070.130.13

MERCURYLAB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

MERCURYLAB Stock Peers

MERCURYLAB Past Performance & Peer Comparison

MERCURYLAB Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Mercury Laboratories Ltd32.482.010.41%
Sun Pharmaceutical Industries Ltd36.185.890.97%
Cipla Ltd22.954.511.07%
Dr Reddy's Laboratories Ltd19.323.870.61%

MERCURYLAB Stock Price Comparison

Compare MERCURYLAB with any stock or ETF
Compare MERCURYLAB with any stock or ETF
MERCURYLAB
Loading...

MERCURYLAB Holdings

MERCURYLAB Shareholdings

MERCURYLAB Promoter Holdings Trend

MERCURYLAB Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

MERCURYLAB Institutional Holdings Trend

MERCURYLAB Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

MERCURYLAB Shareholding Pattern

MERCURYLAB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.66%0.00%0.00%0.00%26.34%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

MERCURYLAB Shareholding History

MERCURYLAB Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

MERCURYLAB Insider Trades & Bulk Stock Deals

MERCURYLAB Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing MERCURYLAB stock

smallcases containing MERCURYLAB stock

Looks like this stock is not in any smallcase yet.

MERCURYLAB Events

MERCURYLAB Events

MERCURYLAB Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MERCURYLAB has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.41%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.12 every year

Dividends

Corp. Actions

Announcements

Legal Orders

MERCURYLAB Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MERCURYLAB has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.41%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.12 every year

MERCURYLAB Upcoming Dividends

MERCURYLAB Upcoming Dividends

No upcoming dividends are available

MERCURYLAB Past Dividends

MERCURYLAB Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2024

Final
Final | Div/Share: ₹3.50

Dividend/Share

3.50

Ex DateEx Date

Sep 20, 2024

Cash Dividend

Ex DateEx DateSep 20, 2023

Final
Final | Div/Share: ₹3.50

Dividend/Share

3.50

Ex DateEx Date

Sep 20, 2023

Cash Dividend

Ex DateEx DateSep 19, 2022

Final
Final | Div/Share: ₹3.50

Dividend/Share

3.50

Ex DateEx Date

Sep 19, 2022

Cash Dividend

Ex DateEx DateSep 20, 2021

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 20, 2021

Cash Dividend

Ex DateEx DateFeb 22, 2021

Interim
Interim | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Feb 22, 2021

MERCURYLAB Stock News & Opinions

MERCURYLAB Stock News & Opinions

Earnings
Mercury Laboratories standalone net profit declines 41.88% in the March 2025 quarter

Net profit of Mercury Laboratories declined 41.88% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 1.91 crore during the previous quarter ended March 2024. Sales rose 18.94% to Rs 20.66 crore in the quarter ended March 2025 as against Rs 17.37 crore during the previous quarter ended March 2024. For the full year,net profit declined 44.42% to Rs 3.14 crore in the year ended March 2025 as against Rs 5.65 crore during the previous year ended March 2024. Sales declined 0.61% to Rs 75.10 crore in the year ended March 2025 as against Rs 75.56 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales20.6617.37 19 75.1075.56 -1 OPM %10.3115.31 -9.3511.95 - PBDT2.182.97 -27 7.549.74 -23 PBT1.452.25 -36 4.666.92 -33 NP1.111.91 -42 3.145.65 -44 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mercury Laboratories schedules AGM

Mercury Laboratories announced that the 44th Annual General Meeting(AGM) of the company will be held on 13 August 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Mercury Laboratories recommends final dividend

Mercury Laboratories announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 35%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mercury Laboratories to announce Quarterly Result

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Mercury Laboratories standalone net profit declines 4.03% in the December 2024 quarter

Net profit of Mercury Laboratories declined 4.03% to Rs 1.19 crore in the quarter ended December 2024 as against Rs 1.24 crore during the previous quarter ended December 2023. Sales rose 14.38% to Rs 19.57 crore in the quarter ended December 2024 as against Rs 17.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales19.5717.11 14 OPM %10.1213.03 - PBDT2.382.31 3 PBT1.641.59 3 NP1.191.24 -4 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Mercury Laboratories to table results

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Mercury Laboratories standalone net profit declines 66.89% in the September 2024 quarter

Net profit of Mercury Laboratories declined 66.89% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales declined 20.08% to Rs 18.19 crore in the quarter ended September 2024 as against Rs 22.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales18.1922.76 -20 OPM %7.1510.94 - PBDT1.362.74 -50 PBT0.652.03 -68 NP0.501.51 -67 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Mercury Laboratories schedules board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Mercury Laboratories schedules AGM

Mercury Laboratories announced that the 43th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Mercury Laboratories standalone net profit declines 66.00% in the June 2024 quarter

Net profit of Mercury Laboratories declined 66.00% to Rs 0.34 crore in the quarter ended June 2024 as against Rs 1.00 crore during the previous quarter ended June 2023. Sales declined 8.95% to Rs 16.68 crore in the quarter ended June 2024 as against Rs 18.32 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales16.6818.32 -9 OPM %9.659.12 - PBDT1.621.74 -7 PBT0.921.06 -13 NP0.341.00 -66 Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Mercury Laboratories Ltd (MERCURYLAB) today?

    The share price of MERCURYLAB as on 20th June 2025 is ₹829.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Mercury Laboratories Ltd (MERCURYLAB) share?

    The past returns of Mercury Laboratories Ltd (MERCURYLAB) share are
    • Past 1 week: -1.52%
    • Past 1 month: 0.86%
    • Past 3 months: -0.56%
    • Past 6 months: -9.87%
    • Past 1 year: -6.64%
    • Past 3 years: 92.37%
    • Past 5 years: 122.10%

  3. What are the peers or stocks similar to Mercury Laboratories Ltd (MERCURYLAB)?
  4. What is the dividend yield % of Mercury Laboratories Ltd (MERCURYLAB) share?

    The current dividend yield of Mercury Laboratories Ltd (MERCURYLAB) is 0.41.

  5. What is the market cap of Mercury Laboratories Ltd (MERCURYLAB) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mercury Laboratories Ltd (MERCURYLAB) is ₹102 Cr as of 20th June 2025.

  6. What is the 52 week high and low of Mercury Laboratories Ltd (MERCURYLAB) share?

    The 52-week high of Mercury Laboratories Ltd (MERCURYLAB) is ₹1190 and the 52-week low is ₹736.

  7. What is the PE and PB ratio of Mercury Laboratories Ltd (MERCURYLAB) stock?

    The P/E (price-to-earnings) ratio of Mercury Laboratories Ltd (MERCURYLAB) is 32.48. The P/B (price-to-book) ratio is 2.01.

  8. Which sector does Mercury Laboratories Ltd (MERCURYLAB) belong to?

    Mercury Laboratories Ltd (MERCURYLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Mercury Laboratories Ltd (MERCURYLAB) shares?

    You can directly buy Mercury Laboratories Ltd (MERCURYLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.